Literature DB >> 21209229

A thorough electrocardiogram study of edoxaban, a novel factor Xa inhibitor.

J Mendell1, R Basavapathruni, D Swearingen, A Draves, G Zhang, J Morganroth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21209229     DOI： 10.1177/0091270010381901

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  7 in total

1.  Edoxaban: a new oral direct factor xa inhibitor.

Authors:  A John Camm; Henri Bounameaux
Journal:  Drugs       Date:  2011-08-20       Impact factor: 9.546

Review 2.  Edoxaban: A Review in Deep Vein Thrombosis and Pulmonary Embolism.

Authors:  Matt Shirley; Sohita Dhillon
Journal:  Drugs       Date:  2015-11       Impact factor: 9.546

Review 3.  Pharmacokinetics and Pharmacodynamics of Edoxaban, a Non-Vitamin K Antagonist Oral Anticoagulant that Inhibits Clotting Factor Xa.

Authors:  Dolly A Parasrampuria; Kenneth E Truitt
Journal:  Clin Pharmacokinet       Date:  2016-06       Impact factor: 6.447

4.  Drug-drug interaction studies of cardiovascular drugs involving P-glycoprotein, an efflux transporter, on the pharmacokinetics of edoxaban, an oral factor Xa inhibitor.

Authors:  Jeanne Mendell; Hamim Zahir; Nobuko Matsushima; Robert Noveck; Frank Lee; Shuquan Chen; George Zhang; Minggao Shi
Journal:  Am J Cardiovasc Drugs       Date:  2013-10       Impact factor: 3.571

Review 5.  Edoxaban: an update on the new oral direct factor Xa inhibitor.

Authors:  Henri Bounameaux; A John Camm
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546

Review 6.  Comparative risk impact of edoxaban in the management of stroke and venous thromboembolism.

Authors:  Katie B Tellor; Joseph S Van Tuyl; Anastasia L Armbruster
Journal:  Ther Clin Risk Manag       Date:  2016-04-26       Impact factor: 2.423

Review 7.  Drug-Drug Interactions of 257 Antineoplastic and Supportive Care Agents With 7 Anticoagulants: A Comprehensive Review of Interactions and Mechanisms.

Authors:  Érique José F Peixoto de Miranda; Thamy Takahashi; Felipe Iwamoto; Suzete Yamashiro; Eliana Samano; Ariane Vieira Scarlatelli Macedo; Eduardo Ramacciotti
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.